Imunon (IMNN) Short Interest Ratio & Short Volume → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free IMNN Stock Alerts $1.47 0.00 (0.00%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends Imunon Short Interest DataCurrent Short Interest352,900 sharesPrevious Short Interest367,200 sharesChange Vs. Previous Month-3.89%Dollar Volume Sold Short$497,589.00Short Interest Ratio1.7 Days to CoverLast Record DateMay 15, 2024Outstanding Shares9,400,000 sharesFloat Size9,290,000 sharesShort Percent of Float3.80%Today's Trading Volume5,751 sharesAverage Trading Volume152,238 sharesToday's Volume Vs. Average4% Short Selling Imunon ? Sign up to receive the latest short interest report for Imunon and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIMNN Short Interest Over TimeIMNN Days to Cover Over TimeIMNN Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Imunon Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/2024352,900 shares $497,589.00 -3.9%3.8%1.7 $1.41 4/30/2024367,200 shares $481,032.00 -20.8%4.0%1.7 $1.31 4/15/2024463,400 shares $681,198.00 +4.5%5.0%2.1 $1.47 3/31/2024443,300 shares $727,012.00 -1.3%4.8%2.2 $1.64 3/15/2024449,100 shares $386,226.00 -8.6%4.8%3 $0.86 2/29/2024491,200 shares $559,968.00 -5.7%5.3%3.3 $1.14 Get the Latest News and Ratings for IMNN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024520,600 shares $275,918.00 +96.8%5.6%8.8 $0.53 1/31/2024264,600 shares $136,533.60 +128.7%2.8%5.2 $0.52 1/15/2024115,700 shares $77,056.20 +120.8%1.2%2.6 $0.67 12/31/202352,400 shares $35,632.00 +277.0%0.6%1.4 $0.68 12/15/202313,900 shares $12,857.50 +139.7%0.2%0.4 $0.93 11/30/20235,800 shares $5,220.00 -45.3%0.1%0.3 $0.90 11/15/202310,600 shares $10,275.64 -11.7%0.1%0.5 $0.97 10/31/202312,000 shares $11,880.00 -29.4%0.1%0.5 $0.99 10/15/202317,000 shares $16,660.00 -23.8%0.2%0.8 $0.98 9/30/202322,300 shares $21,907.52 -39.1%0.2%0.9 $0.98 9/15/202336,600 shares $43,188.00 -33.9%0.4%1.6 $1.18 8/31/202355,400 shares $69,250.00 +1,951.9%0.6%2 $1.25 8/15/20232,700 shares $3,186.00 -82.2%0.0%0.1 $1.18 7/31/202315,200 shares $19,152.00 +390.3%0.2%0.5 $1.26 7/15/20233,100 shares $3,937.00 +10.7%0.0%0.1 $1.27 6/30/20232,800 shares $3,612.00 -47.2%0.0%0.1 $1.29 6/15/20235,300 shares $6,890.00 -59.5%0.1%0.1 $1.30 5/31/202313,100 shares $15,458.00 -44.5%0.1%0.3 $1.18 5/15/202323,600 shares $31,758.52 No Change0.3%0.4 $1.35 IMNN Short Interest - Frequently Asked Questions What is Imunon's current short interest? Short interest is the volume of Imunon shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 352,900 shares of IMNN short. 3.80% of Imunon's shares are currently sold short. Learn More on Imunon's current short interest. What is a good short interest ratio for Imunon? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMNN shares currently have a short interest ratio of 2.0. Learn More on Imunon's short interest ratio. What is a good short interest percentage for Imunon? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.80% of Imunon's floating shares are currently sold short. Is Imunon's short interest increasing or decreasing? Imunon saw a decline in short interest in May. As of May 15th, there was short interest totaling 352,900 shares, a decline of 3.9% from the previous total of 367,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Imunon's float size? Imunon currently has issued a total of 9,400,000 shares. Some of Imunon's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Imunon currently has a public float of 9,290,000 shares. How does Imunon's short interest compare to its competitors? 3.80% of Imunon's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Imunon: Pluri Inc. (0.77%), Rockwell Medical, Inc. (2.11%), Anebulo Pharmaceuticals, Inc. (0.07%), Tharimmune, Inc. (0.17%), Kezar Life Sciences, Inc. (5.10%), Equillium, Inc. (1.61%), Eagle Pharmaceuticals, Inc. (9.97%), CASI Pharmaceuticals, Inc. (0.83%), Aadi Bioscience, Inc. (5.54%), Kronos Bio, Inc. (1.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Imunon stock? Short selling IMNN is an investing strategy that aims to generate trading profit from Imunon as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Imunon? A short squeeze for Imunon occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMNN, which in turn drives the price of the stock up even further. How often is Imunon's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMNN, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Pluri Short Interest Data Rockwell Medical Short Interest Data Anebulo Pharmaceuticals Short Interest Data Tharimmune Short Interest Data Kezar Life Sciences Short Interest Data Equillium Short Interest Data Eagle Pharmaceuticals Short Interest Data CASI Pharmaceuticals Short Interest Data Aadi Bioscience Short Interest Data Kronos Bio Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IMNN) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarGold Set to EXPLODE!Gold Safe ExchangeWrite this ticker symbol down…StocksToTradeWho are Nvidia’s New Silent Partners?Weiss RatingsThe 7th Trillion Dollar Company?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.